Benzinga··Vandana SinghEli Lilly's Dual-Therapy Approach Demonstrates Enhanced Efficacy in Psoriasis-Obesity Treatment
Eli Lilly's combo therapy of Taltz and Zepbound showed superior results for psoriasis-obesity patients, achieving 27.1% complete skin clearance versus 5.8% for monotherapy.
LLYCSLLYPhase 3b trialZepbound